Yousif Capital Management LLC Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Yousif Capital Management LLC grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,958 shares of the company’s stock after buying an additional 4,768 shares during the quarter. Yousif Capital Management LLC’s holdings in GE HealthCare Technologies were worth $5,391,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sargent Investment Group LLC lifted its stake in GE HealthCare Technologies by 5.8% in the fourth quarter. Sargent Investment Group LLC now owns 3,914 shares of the company’s stock worth $334,000 after acquiring an additional 215 shares during the period. E. Ohman J or Asset Management AB raised its holdings in shares of GE HealthCare Technologies by 10.9% in the 4th quarter. E. Ohman J or Asset Management AB now owns 20,300 shares of the company’s stock valued at $1,587,000 after purchasing an additional 2,000 shares in the last quarter. Mather Group LLC. lifted its position in shares of GE HealthCare Technologies by 14.3% in the 4th quarter. Mather Group LLC. now owns 1,977 shares of the company’s stock worth $155,000 after purchasing an additional 247 shares during the period. Brown Lisle Cummings Inc. boosted its stake in shares of GE HealthCare Technologies by 33.0% during the fourth quarter. Brown Lisle Cummings Inc. now owns 605 shares of the company’s stock valued at $47,000 after purchasing an additional 150 shares in the last quarter. Finally, Tandem Capital Management Corp ADV increased its holdings in GE HealthCare Technologies by 0.4% during the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock valued at $2,205,000 after buying an additional 118 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $88.55 on Friday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The business has a fifty day moving average of $83.25 and a 200 day moving average of $85.17. The firm has a market capitalization of $40.46 billion, a price-to-earnings ratio of 24.33, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.55.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

Analyst Ratings Changes

Several analysts have issued reports on GEHC shares. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.